Activation of the EIF2α/ATF4 and ATF6 Pathways in DU-145 Cells by Boric Acid at the Concentration Reported in Men at the US Mean Boron Intake
- 1.2k Downloads
Fruits, nuts, legumes, and vegetables are rich sources of boron (B), an essential plant nutrient with chemopreventive properties. Blood boric acid (BA) levels reflect recent B intake, and men at the US mean intake have a reported non-fasting level of 10 μM. Treatment of DU-145 prostate cancer cells with physiological concentrations of BA inhibits cell proliferation without causing apoptosis and activates eukaryotic initiation factor 2 (eIF2α). EIF2α induces cell differentiation and protects cells by redirecting gene expression to manage endoplasmic reticulum stress. Our objective was to determine the temporal expression of endoplasmic reticulum (ER) stress-activated genes in DU-145 prostate cells treated with 10 μM BA. Immunoblots showed post-treatment increases in eIF2α protein at 30 min and ATF4 and ATF6 proteins at 1 h and 30 min, respectively. The increase in ATF4 was accompanied by an increase in the expression of its downstream genes growth arrest and DNA damage-induced protein 34 (GADD34) and homocysteine-induced ER protein (Herp), but a decrease in GADD153/CCAAT/enhancer-binding protein homologous protein (CHOP), a pro-apoptotic gene. The increase in ATF6 was accompanied by an increase in expression of its downstream genes GRP78/BiP, calreticulin, Grp94, and EDEM. BA did not activate IRE1 or induce cleavage of XBP1 mRNA, a target of IRE1. Low boron status has been associated with increased cancer risk, low bone mineralization, and retinal degeneration. ATF4 and BiP/GRP78 function in osteogenesis and bone remodeling, calreticulin is required for tumor suppressor p53 function and mineralization of teeth, and BiP/GRP78 and EDEM prevent the aggregation of misfolded opsins which leads to retinal degeneration. The identification of BA-activated genes that regulate its phenotypic effects provides a molecular underpinning for boron nutrition and biology.
KeywordsATF4 ATF6A Boric acid Boron Calreticulin (CALR) EDEM1 eIF2α (EIF2A) GADD34 (PPP1R15A) GADD153/CHOP (DDIT3) GRP78/BiP (HSPa5) GRP94 (HSP90B1) Herp (HERPUD1) Hrd1 (SYVN1) RE1 (ERN1) XBP1 DU-145 Nutrition
Cyclic ADP ribose
Unfolded protein response
Growth arrest and DNA damage-inducible protein 34
Homocysteine-responsive endoplasmic reticulum resident ubiquitin-like domain member 1 protein
CCAAT/enhancer-binding protein homologous protein
Binding immunoglobulin protein (BiP) (also known as 78-kDa glucose-regulated protein)
94-kDa glucose-regulated (also known as protein heat shock protein 90-kDa beta member 1)
Xbox binding protein
ER degradation enhancer mannosidase alpha-like 1
Ribonuclear protein particles
Activating transcription factor 4
Integrated stress response
Endoplasmic reticulum stress response element 1
Boron (B) intake is associated with reduced risk of prostate cancer in men [1, 2, 3, 4, 5], lung cancer in women , improvement in executive brain function , bone mineralization and strength [8, 9, 10], and a decrease in inflammation in animals . Plants require boron as an essential nutrient and are the major source of boron in the human diet . Greater than 90 % of dietary boron is absorbed and distributed to tissues as boric acid (BA) (WHO 1998) with 98 % eliminated in the urine after 120 h (Jansen et al. 1984). A study of men working in a large boric acid borax production plant found no differences in boron blood levels between workers with high and low occupational  exposure at the beginning of their 5-day work week . Monday pre-shift non-fasting blood BA levels averaged 9.7 μM in these workers whose average dietary intake of 1.35 mg B/day was near the mean US intake of 1.42 mg/day for men over 30 years of age .
Human prostate cells were developed as a model for investigating the molecular cell biology of BA after epidemiological evidence showed that boron was associated with reduced risk of prostate cancer [3, 5]. Treatment of LNCaP and DU-145 prostate cancer cells with physiological concentrations or BA inhibits cell proliferation in a dose-dependent manner  without causing apoptosis but shifts them into a senescent-like phenotype [5, 14]. BA binds to cADPR and inhibits cADPR-activated Ca2+ release from the endoplasmic reticulum (ER) in a dose-dependent manner [15, 16] and lowers ER luminal Ca2+ concentrations. Low ER luminal Ca2+ induces phosphorylation of eIF2α, a major regulator of cellular responses to environmental stress . In MEF cells, low activation of eIF2α activates the transcription factor ATF4 which induces genes in the integrated stress response, but not the CCAAT/enhancer-binding protein homologous protein (CHOP), an apoptotic gene, whereas high activation induces CHOP. Phosphorylation of eIF2α occurs following BA treatment of DU-145 and LNCaP prostate cells [18, 19, 20] and yeast . In humans, blood levels of BA are dynamic, rising rapidly after a meal with an elimination half-life from 4 to 27.8 h depending on dose [22, 23]. Here, we treated DU-145 cells with a constant BA concentration of 10 μM, the level reported in men at the mean US boron dietary intake, and measured the temporal response of genes in the ER stress pathways.
DMSO, DTT, boric acid, NaCl, Tris, methanol, MgCl2, sucrose, and methanol were purchased from Sigma-Aldrich (St. Louis, MO). Triton X-100, Tween-20, NP40, and cycloheximide were purchased from Fisher Scientific (Pittsburg, PA). Paraformaldehyde was purchased from Affymetrix/USB Corporation (Cleveland, OH). Thapsigargin and BSA were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Phosphatase inhibitors and protease were purchased from Calbiochem (San Diego, CA), and fetal bovine serum (FBS) was purchased from Gibco-Life Sciences (Grand Island, NY).
DU-145 prostate cancer cells were purchased from the American Type Culture Collection (Manassas, VA) and sub-cultured at a ratio of 1:6 and used for seven passages. The ATCC description of the DU-145 karyotype is given in Supplement 2 . DU-145 is included in the COSMIC Cell Line Project, and available information for each gene measured in this paper is given in Tables 1-6 of Supplement 2. The cell culture medium was RPMI-1640 Medium (Gibco-Life Technologies, Grand Island, NY) supplemented with 10 % FBS, l-glutamine (200 mM), streptomycin (100 μg/mL), and penicillin (100 U/mL) (Gemini Bio Products, Sacramento, CA). Cells were plated on 10- or 15-cm plates (Corning Life Sciences, Corning, NY) and incubated in a humidified chamber at 37 °C and 5 % CO2 and 95 % air to 80 % confluency. Media used for all treatment groups were first stripped of boron by shaking with 2 g of Amberlite IRA 743 exchange resin (Sigma-Aldrich) for 12 h at 4 °C. H2O or BA (10 mM) was added respectfully to prepare untreated and 10 μM BA cell culture media . Cells were cultured in untreated media until 80 % confluency and sub-cultured for experiments using untreated media or media adjusted to 10 μM BA.
Polysome profiles were developed from untreated and BA-treated cells obtained from paired culture plates and processed in parallel. Plated cells were incubated in culture media containing 50 μg/mL cycloheximide for 10 min at 37 °C. Plates were then chilled on ice, the media removed, and cells were rinsed two to three times with ice-cold PBS containing 50 μg/mL cycloheximide. The cells were lysed in 500 μl lysis buffer (20 mM Tris (pH 7.5), 100 mM NaCl, 10 mM MgCl2, 0.4 % NP-40, 50 μg/mL cycloheximide, and protease and phosphatase inhibitors. The lysate was scraped with a spatula (Corning) and transferred to a microcentrifuge tube. The lysate was passed through a sterile 23-gauge needle (BD, Franklin Lakes, NJ) 8–10 times and incubated on ice for 10 min. The lysate was centrifuged at 8000×g for 10 min, and the supernatant was used for the polysome profile. The gradient was prepared by filling a SW41 centrifuge tube approximately halfway with 10 % gradient solution [20 mM Tris–HCl, pH 7.5, 100 mM NaCl, 5 mM MgCl2, 0.5 mM DTT, 0.1 mg/mL cycloheximide, and 10 % sucrose (w/v)]. A 23-gauge needle was used to add solution containing 20 mM Tris–HCl, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 0.5 mM DTT, 0.1 mg/mL cycloheximide, and 50 % (v/w) sucrose to the bottom of the tube to form the lower layer. A gradient maker was used to create a 10–50 % gradient. Lysate with OD of 10 (up to 800 μl) was gently added to the top of the gradient. The tubes were balanced, gently placed in a pre-cooled SW41 rotor (Beckman Coulter, Brea, CA), and centrifuged for 3 h at 35,000 rpm. Fifty fractions were collected through a 23-gauge needle inserted through the bottom of the tube and immediately placed on ice. The absorbance of each fraction was measured at 254 nm. Monosomes and polysomes were quantified by measuring the area under the 80S monosomal peak and the area under the polysomes using the trapezoidal area under the curve method.
DU-145 cells were grown to 80 % confluency on 15-cm plates (Corning) and treated with 10 μM BA, 1 μM thapsigargin, or DMSO positive control vehicle for various times. Cells were washed with ice-cold phosphate buffer solution (PBS) supplemented with 0.1 % Tween (PBST) and treated with 100 μl radioimmunoprecipitation assay (RIPA) lysis buffer. Actin and GAPDH were used as loading controls and selected based on their molecular mass band separation from the protein of interest. Cells were scraped from plates using a spatula (Corning) placed on ice, and the lysate was passed through a 23-gauge needle (BD) 8–10 times. The protein was quantitated using Coomassie Plus Protein Assay (Thermo-Scientific, Waltham, MA). Aliquots containing 30–35 μg protein sample were separated using a 4–12 % gradient TGX SDS-PAGE (Bio-Rad, Hercules, CA) at 200 V for 30 min. Protein was transferred to a nitrocellulose membrane using a transfer buffer containing 20 % methanol at 40 V for 1.5 h. Membranes were blocked in 3 % BSA with 37.5 mM Tris (pH 8.8), 0.1 % Tween 20, and 125 mM NaCl for at least 4 h. Antibodies were selected from commercial suppliers based on their specificity for human orthologs and validated by comparison of immunoblot bands to standard molecular mass ladders (Bio-Rad). Antibody dilutions were selected based on testing of lots prior to use in experiments and ranged from 1:200 to 1:1000. Blocked membranes were incubated with the primary antibody for 1 h in PBST or 3 % BSA blocking solution and washed in PBST. They were then incubated with a secondary antibody with an HRP tag, followed by washing three times with PBST. The membranes were exposed to ECL Plus (Amersham/GE Healthcare, Pittsburg, PA) for 2–5 min and imaged using a Typhoon 9410 Variable Mode Imager (Amersham). Densitometry was performed using ImageQuant 5.2 software (Molecular Dynamics, Pittsburg, PA). All secondary antibodies were purchased from Santa Cruz Biotechnologies (Santa Cruz, CA). The following primary antibodies from Santa Cruz Biotechnology were used: GRP78/BiP (mouse monoclonal), Actin (goat polyclonal), GAPDH (mouse monoclonal), ATF4 (rabbit polyclonal), GADD34 (rabbit polyclonal), CHOP/Gadd153 (rabbit polyclonal), XBP-1 (rabbit polyclonal), and ATF6α (rabbit polyclonal). The eIF2α (rabbit polyclonal) and ph-eIF2α (rabbit polyclonal) antibodies were purchased from Cell Signaling (Danvers, MA), and ATF6 (mouse monoclonal) was purchased from Imgenex (San Diego, CA).
TaqMan Real-Time PCR
DU-145 cells were grown on 10-cm plates (Corning) to 80 % confluency at least 24 h prior to treatment. Cells were treated with 10 μM BA, 1 μM thapsigargin, or DMSO vehicle for varying time points. RNA was isolated from cells at indicated time points (0, 0.25, 0.5, 1, 2, 3, 4, 5, 6, 12, or 24 h) using an RNeasy Mini Kit (Qiagen, Valencia, CA). Total RNA (2 μg) was reverse transcribed using Superscript III Reverse Transcriptase (Invitrogen) with random hexamer primers (Invitrogen) at a final volume of 20 μl at 25 °C, 10 min (10:00); 50 °C, 45:00; and 70 °C, 15:00. Applied Biosystems (ABI, Foster City, CA) TaqMan pre-designed assays were used for all genes as well as GAPDH as a control internal housekeeping gene. Plates were read by a 7500 Fast Real-Time PCR System using the 7500 Fast System Software v1.4.0 (ABI). Quantitation of gene expression levels was calculated from a standard curve created from reactions containing a combination of complementary DNA (cDNA) from all treatments for each gene.
DU-145 cells were grown to 80 % confluency on glass coverslips (Fisher Scientific, Pittsburg, PA) and treated with either BA-free media, 10 μM BA, or 1 μM thapsigargin. Antibodies were tested on immunoblots of lysed cells prior to using them for immunohistochemistry. Cells stained for ATF6 were first fixed with 4 % paraformaldehyde in PBS and permeabilized with 0.5 % Triton X-100 in PBS. Fixed cells were blocked with 10 % FBS in PBS overnight. The next day, they were moved to a humidity chamber and incubated with anti-ATF6 (Imgenex, San Diego, CA) monoclonal antibody at a concentration of 1:50, followed by secondary Alexa 488 or FITC at 1:100. Coverslips were mounted with a mixture of Vectashield with 4′,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA) and regular Vectashield HardSet (Vector Laboratories) mounting mediums at 1:5. Images were captured with an Olympus DP72 camera (Olympus America, Center Valley, PA) connected to an Olympus BX51 fluorescence microscope (Olympus America) using an Olympus UIS2 UPlanFLN 100X/1.30 OilPh3 objective (Olympus America) and FITC and DAPI filters. Olympus DP2-BSW (Olympus America) or Adobe Photoshop (Adobe Systems Incorporated, San Jose, CA) software was used to merge and crop images.
XBP1 Cleavage Analysis
Total RNA was extracted from BA (0–250 μM)-treated or thapsigargin (10 μM)-treated DU-145 cells using RNeasy Mini Kit (Qiagen). RNA was reverse transcribed using SuperScript III Reverse Transcriptase (Invitrogen). XBP1 cDNA was amplified with GoTaq Flexi DNA Polymerase (Promega, Madison WI) using the forward primer 5ʹ-CACCTGAGCCCCGAGGAG-3ʹ and reverse primer 5ʹ-TTAGTTCATTAATGGCTTCCAGC-3ʹ [HGNC:12801; NCBI Reference Sequence: NM_005080.3]. Fifty-microliter PCR reactions were run under the following amplification conditions: 95 °C for 2 min; 95 °C for 30 s, 60 °C for 30 s, 72 °C for 30 s, all for 25 cycles; and 72 °C for 5 min . PCR products were run on 2 % agarose E-gels with SYBR Safe (Invitrogen) or 4 % ethidium bromide agarose gels (Fig. 11).
SigmaStat 3.1 (Systat Software, Point Richmond, CA) was used for analysis of data and selection of appropriate statistical tests. Results of the statistical analysis for each figure are provided in Supplement 1 Polysome profiles were developed from untreated and BA-treated cells obtained from paired culture plates processed in parallel. Monosomes and polysomes were quantified by measuring the area under the 80S monosomal peak and the area under the polysomes using the trapezoidal area under the curve method. The difference in means of polysome/monosome ratios from three independent experiments run on different days was evaluated using a paired t test. Replicates of data in Figs. 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 represent cells plated from different seedings on different days. Analysis of timed studies used a one-way repeated measures analysis of variance to determine the effect of treatment time. Differences between the mean at pre-treatment time zero (control) and means at post-treatment time points were evaluated using the Holm–Sidak multiple comparison test. The number of replicates for each significant time point is given in the figure legends and Supplement 1. ImageJ software (NIH, Bethesda, MD) was used for immunofluorescence quantitation of stained cells. Only cells with clear borders of the ER and nucleus were selected for study. Mean intensity of nuclear and cytoplasmic areas of identical size was determined using the histogram tool in RGB mode. For ATF6 images, the polygon tool was used to trace the outer edges of the FITC and DAPI-stained areas and the ER was calculated by subtracting the area of the DAPI from the area of the FITC. Proof that DU-145 cells were capable of activating the genes under study was obtained by treatment with 1 μM thapsigargin, a strong inducer of ER stress that activates apoptosis . The statistical significance of thapsigargin treatment in Figs. 2, 3, 4, 6, 8, 9, 10, and 12 was compared to treatment with its solvent DMSO using a t test.
Availability of Supporting Data
Supplement 1 contains tables of statistical evaluations of the data for each figure. Supplement 2 gives the ATCC karyotype description of DU-145 and mutation status of genes available in COSMIC and Ensemble in Tables 1–6 .
BA Causes a Decrease in the Polysome/Monosome Ratio
BA Induces Phosphorylation of eIF2α
BA Induces GADD34 Transcription and Translation
Time of maximum response of untreated cells (0 min) to treatment with 10 μm boric acid
Measured response; maximum change; post-treatment timea
Eukaryotic translation initiation factor (EIF2A)
Phosphorylation; +125 %; 60 min
Activating transcription factor 4 (ATF4)b
mRNA; +46 %; 2 h
Protein; +53 %; 3 h
Growth arrest and DNA damage-inducible protein 34 (GADD34); Protein phosphatase 1 regulatory subunit 15A (PPP1R15A)
mRNA; +125 %; 2 h
Protein; +53 %; 2 h
DNA damage inducible transcript 3 (CHOP; GADD153; DDIT3)
mRNA; −59 %; 12 h
Protein; −51 %; 3 h
Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 (HERP, HERPUD1)
mRNA; +56 %; 4 h
Activating transcription factor 6A (ATF6A)c
Cleavage p70/p100; +77 %; 30 min
Nuclear/cytoplasm staining; +29 %; 2 h
Heat shock protein family A (Hsp70)
member 5 (GRP78; BiP; HSPA5)
mRNA; +149 %; 30 min
Protein; +98 %; 60 min
ER degradation enhancer, mannosidase
alpha-like 1 (EDEM1)
mRNA; +110 %; 24 h
Heat shock protein 90-kDa beta family
member 1 (GRP94; HSP90B1)
mRNA no change
mRNA; +52 %; 8 h
X-box binding protein 1 (XBP1)
mRNA; +147 %; 24 h
Endoplasmic reticulum to nucleus signaling 1 (IRE1; ERN1)c
No change or negative change
X-box binding protein 1 spliced (XBP1s)
Spliced XBP1 (XBP1s) was not observed at 0–250 μM BA
Synoviolin 1 (HRD1; SYVN1)
mRNA; −34 %; 24 h
BA Increases GRP78/BiP Transcription and Translation
BA Induces ATF4 Transcription and Translation
BA Induces GADD34 and Herp but Decreases CHOP Transcription
BA Decreases CHOP Protein
BA Induces ATF6 Activation
BA Increases Transcription of ATF6 Target Genes
BA Does Not Activate the IRE1 Branch of UPR
BA Does Not Activate Hrd1, a Spliced XBP1-Specific Target Gene
Genes Were Active in the DU-145 Cell Line
The positive control, thapsigargin, demonstrated that all genes evaluated were active in the DU-145 cell line. The Catalogue of Somatic Mutations in Cancer (COSMIC) recorded a mutation in ATF4 in 16.67 % of prostate tumor tissue samples . In the DU-145 cell line, substitution mutations were reported in ATF4 and IRE1 with no phenotypic changes. The mutations did not occur in the regulatory build, and no association was found for any gene measured and copy number or expression in the COSMIC Cell Line. Information available in COSMIC (releases v75 and v76) and Ensemble for each of the genes measured in this manuscript are available in Supplement 2 [28, 41]. ATCC states that DU-145 “is a hypotriploid human cell line. Both 61 and 62 chromosome numbers had the highest rate of occurrence in 30 metaphase counts. The rate of higher ploides was 3 %. The t(11q12q), del(11)q23), 16q+, del(9)(p11),del(1)(p32) and 6 other marker chromosomes were found in most cells. The N13 was usually absent. The Y chromosome is abnormal through translocation to an unidentified chromosomal segment. The X chromosome was present in single copy.”
We describe in this paper the response of DU-145 human prostate cells to concentrations of BA that occur from dietary exposure. We draw seven main conclusions from our results. First, BA reduces the polysome/monosome ratio, an indicator of global protein translation. Changes to the extracellular environment can alter intracellular conditions that stress the ER and inhibit global protein synthesis. Documented stresses include low ER luminal [Ca2+]; nutrient stress from glucose deprivation and amino acid deficiency; and toxic exposures from chemical, physical, and biological hazards (NaN3, arsenite, oxidants, heat, UV radiation, and viruses) [42, 43, 44]. BA treatment lowers luminal ER [Ca2+] as does thapsigargin, a plant sesquiterpene lactone, used widely as a strong positive control to assure that cells under study respond to a known ER stressor . ER stress elicits inhibition in global translation by phosphorylation of eIF-2α which is a component of the heterotrimeric eIF-2 complex that loads the initiator transfer RNA (tRNA) (Met-tRNAMet) onto the 40S ribosomal subunit [45, 46, 47, 48]. The eIF-2 complex binds GTP/GDP, and its activity is regulated by guanine nucleotide exchange factor eIF-2B. Phosphorylation of eIF-2α increases the affinity of eIF-2 for eIF-2B, preventing the exchange of GDP for GTP. This prevents the formation of the puromycin-sensitive 80S pre-initiation complex and allows elongating ribosomes to release mRNAs, leading to the disassembly of polysomes into monosomes . Here, we show that BA (10 μM) treatment reduced the polysome/monosome ratio by approximately half, an indication that global protein synthesis was inhibited, but not stopped (Fig. 1). Uluisik, Kaya, and colleagues reported that 50 mM BA completely halted polysome formation and protein synthesis in yeast .
Second, BA increases the transcription and translation of BiP/GRP78, a resident ER chaperone, with a long half-life (>48 h) and an indicator of ER stress (Figs. 4 and 10) [36, 49]. BiP/GRP78 binds about 20 % of the ER’s Ca2+ and is the master regulator of the UPR [34, 50]. In eukaryotic cells, newly synthesized secretory and transmembrane unfolded polypeptides are transported through translocons into the ER lumen. BiP/GRP78 gates the ER side of the tranlocon [34, 51, 52], recognizes hydrophobic regions of nascent unfolded proteins entering the ER, and assists in their folding and assembly into polypeptides [53, 54]. High [Ca2+]ER is required for protein folding, and when it is low, unfolded proteins accumulate. BiP/GRP78 activates UPR pathways via its release from resident ER transmembrane proteins to remove the stress .
Third, BA activation of eIF2α through phosphorylation at serine 51 is transient. The interaction between BiP/GRP78 and nascent unfolded proteins is stabilized by luminal ER Ca2+, and when Ca2+ concentrations fall, BiP/GRP78 is released and interacts with PERK, a kinase that phosphorylates eIF2α . Treatment of cells with 10 μM BA significantly elevated the ratio of phosphorylated eIF2α/total eIF2α at 30 min, and it remained high up to 2 h (Fig. 2, Table 1). The decline in ph-eif2α coincided with the rise in GADD34 mRNA, the phosphatase that removes the phosphate from ph-eIF2α (Fig. 7a). Our observation of a return to normal suggests that the cell has completed a change in transcription to the new 10-μM BA environment by 3 h and that a comparison of polysomes before BA treatment and at 3 h would provide a means to identify BA-dependent changes in protein translation.
Fourth, BA upregulates the transcription factor, ATF4. Phosphorylation of eIF2α increases upstream open reading frame (uORF)-mediated translation of bone-related activating transcription factor 4 (ATF4). The ph-eIF2α/ATF4 pathway is highly conserved from yeast to mammals and has been named the ISR because it is a target of many different types of environmental stresses . Treatment with BA resulted in an increase in ATF4 mRNA and protein levels (Figs. 5 and 6, Table 1). ATF4-inducible gene GADD34 increased immediately whereas the increase in Herp, which is dually regulated by ATF6 and ATF4 , was delayed to 4 h (Fig. 7b). In neurons, moderate levels of ER stress increase Herp levels, which promotes cell survival by stabilizing ER Ca2+, preserving mitochondrial function and suppressing caspase 3, whereas lethal stress levels decrease Herp levels and induce apoptosis . In neuronal PC12 cells, promotion of cell survival is accomplished by Herp’s association with ryanodine and inositol Ca2+ channels and facilitation of their proteasome-mediated protein degradation .
Fifth, BA reduced the CHOP, also referred to as growth arrest-inducible and DNA damage-inducible gene 153 (GADD153), at both the mRNA and protein levels (Figs. 7c and 8). This outcome is consistent with previous reports showing that BA does not cause apoptosis in DU-145 prostate cells or MDA-MB-231 breast cancer cells at concentrations of 1 mM or less [5, 59]. The absence of CHOP activation by BA is also consistent with the anti-apoptotic activity of BiP/GRP78 and Herp and the absence of BA activation of IRE1 (Figs. 11 and 12a). This can be explained by the low level of eIF2α phosphorylation induced by BA. A single uORF located in the 5′-leader of the CHOP mRNA is responsible for CHOP translation. In non-stress conditions and when eIF2α phosphorylation is low, the uORF serves as a barrier that prevents translation of the downstream CHOP coding region. Lethal stress levels, such as those induced by thapsigargin, induce a high level of eIF2α phosphorylation which facilitates ribosome bypass of the uORF and allows translation .
Sixth, BA activates the ATF6 pathway. BA causes a dose- and time-dependent expansion of the ER with the formation of cytoplasmic stress granules (SGs) . ER expansion is induced by ATF6α  and independently by pXBP1s via the IRE1 pathway [62, 63]. We show here that treatment with BA activated ATF6α, but not IRE1 (Figs. 9, 10, 11, and 12). ATF6 is retained in the ER bound to BiP/GRP78 and dissociates when unfolded proteins accumulate. ATF6 moves to the Golgi where it is cleaved by S1P and S2P proteases to form a soluble basic leucine zipper (bZIP) transcription factor that moves into the nucleus . Nuclear ATF6 binds to an ERSE promoter located upstream of target genes which include BiP/GRP78, calreticulin, and XBP1 . Calreticulin mRNA increased by 49 % at 4 h (Fig. 10c). Calreticulin is a major ER Ca2+-binding protein and increases luminal Ca2+ stores [64, 65]. As a chaperone, it recognizes the terminal glucose and four internal mannoses in newly synthesized glycoproteins . Reductions in ER Ca2+ decrease the formation of these complexes and ER folding capacity. Calreticulin facilitates the folding of major histocompatibility complex (MHC) class I molecules and their assembly factor tapasin, thereby influencing antigen presentation to cytotoxic T cells [67, 68]. It is also required for the stability and nuclear localization of the p53 protein . Further studies are needed to determine if the ability of BA to induce calreticulin transcription is related to its effects on the immune system .
The second ATF6-regulated gene we evaluated was BiP/GRP78. In HeLa cells, thapsigargin induced rapid BiP translation that preceded transcription . The authors suggested that storage of BiP/GRP78 mRNA transcripts allows cells to rapidly synthesize the protein to adapt to small perturbations and reserve transcriptional upregulation for conditions that cause major reductions in the protein level .
ATF6 induces XBP1 mRNA under mild stress whereas higher levels of stress induce XBP1 and IRE1-dependent XBP1(s) . ATF6α forms a heterodimer with XBP1 which induces ER degradation enhancing α-mannosidase-like 1 (EDEM1). EDEM1 enhances the release of terminally misfolded glycoproteins from the calnexin chaperone system. In our study, XBP1 and EDEM1 mRNA were increased by 147 and 110 %, respectively, at the 24-h BA treatment (Fig. 12b, Table 1).
Seventh, BA does not activate IRE1. The IRE1 pathway transactivates the transcription of genes encoding ER chaperones and components required for ERAD . High levels of stress induce XBP1 and XBP1(s) which is translated into the XBP1 transcription factor protein [pXBP1(s)] that binds to ERSE and UPRE DNA-binding sites to induce expression of ER chaperones . IRE1 is required for the site-specific cleavage of XBP1 mRNA into fragments that are subsequently ligated to form the transcript encoding pXBP1(s). We did not observe XBP1 cleavage in BA-treated cells at various doses and time points (Fig. 11) nor was there an increase in transcription of Hrd1, a pXBP1(s)-activated gene (Fig. 12a).
In previous studies using DU-145 and LNCaP prostate cancer cells, we showed that long-term exposure to BA (8 days) induces a senescent-like state and inhibits proliferation in a dose-dependent manner . Long-term exposure to high concentrations of BA (250 and 1000 μM) inhibited both cell migration and invasion . Bradke and colleagues extended these observations to shorter periods of exposure and showed that a 24-h exposure to 1000 μM BA inhibited migration of DU-145 cells on fibronectin . The concentrations used in these migration studies are above what human cells would be exposed to from normal dietary intake and occupational exposure . Dose response studies are needed in migration and other studies to clarify those responses that can be achieved by dietary B intake and those that require pharmaceuticals. The observations presented here suggest caution in interpreting genetic responses to BA since they are time dependent. Understandably, this makes the results of single time-point studies using arrays of multiple genes particularly challenging to interpret. It also seems prudent that BA-sensitive periods be identified prior to conducting dose response experiments.
Dietary boron has been connected to three seemingly unconnected observations, increased bone mass and strength [10, 74, 75], chemoprevention [1, 3, 4, 6], and prevention of retinal degeneration . BiP/GRP78 is expressed in the mineralizing matrices of teeth and bone and in the extracellular matrix of differentiating human marrow stromal cells and dental pulp stem cells. BiP/GRP78 binds to type I collagen and dentin matrix protein 1 and aids in the nucleation of calcium phosphate . ATF4 regulates osteogenesis during development and postnatal bone remodeling and upregulates osteocalcin . Parathyroid hormone, an essential regulator of endochondral bone formation and an important anabolic agent for the reversal of bone loss, mediates its functions in part by regulating the binding of ATF4 to the osteoblast-specific gene, osteocalcin . BiP/GRP78 and EDEM prevent aggregation of misfolded opsin leading to retinal degeneration [80, 81]. Our present observation that BA increased both BiP/GRP78 and EDEM provides a hypothesis for the observed retinal degeneration in B-depleted zebrafish .
BA inhibits the cADPR Ca2+ pathway which activates cell proliferation and inhibits differentiation [15, 82] and activates TIA-1  which has been reported to inhibit tumor progression and invasion . Here, we show that BA treatment increased GRP78 which inhibits cell migration  and calreticulin which suppresses prostate cancer by inhibiting growth and metastasis . Calreticulin is also necessary for p53 function an important tumor suppressor .The eIF2α/ATF4 and ATF6 pathways are downregulated in genetic models of prostate cancer, and their activation by BA is consistent with its reported chemopreventative effect in human populations .
Our studies were performed at a BA concentration that can be achieved by diet. The median consumption of boron in the USA ranges from 0.75 to 1.35 mg B/day in adults and is derived primarily from dietary plants. Borates provide the essential diester link between chains of the pectic polysaccharide rhamnogalactanuran II (RG-II) that is essential for plant growth. RGII occurs in the cell walls of gymnosperms and angiosperms and is a soluble plant fiber that constitutes 15–30 % of dietary fiber . Boron-rich food sources include tree nuts and peanuts, fruits, vegetables, legumes, and wine which, along with olive oil, are the signature of the Mediterranean diet. The NIH-AARP study reported that this diet decreased cancer mortality by 17 % in men and 13 % in women during a 5-year study period . Determining how important boron was to this outcome will require teasing out the relative contributions of dietary components. In the meantime, we find it of interest that coffee in North America and soybeans in China are the major contributors of boron to the diet [89, 90], and both have been associated with reduced risk of prostate cancer [91, 92].
UC Toxic Substances and Training Grant to the UCLA Molecular Toxicology Program provided partial support for SK, KH, and KY. Other support was provided from remunerations for teaching for CE.
Compliance with Ethical Standards
This article does not contain any studies with human or animal subjects performed by any of the authors.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 4.Muezzinoglu T, Korkmaz M, Nese N, Bakirdere S, Arslan Y, et al. (2011) Prevalence of prostate cancer in high boron-exposed population: a community-based study. Biol Trace Elem ResGoogle Scholar
- 10.Nielsen FH, Stoecker BJ (2009) Boron and fish oil have different beneficial effects on strength and trabecular microarchitecture of bone. J Trace Elem Med Biol 23: 195–203.Google Scholar
- 12.IOM (2001) Dietary reference intakes for vitamin a, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academy Press, Washington, D.C.Google Scholar
- 19.Henderson KA, Eckhert CD (2006) Boric acid induces ER stress and UPR in human prostate DU-145 and LNCaP cancer cells. FASEB J 20:A560Google Scholar
- 20.Henderson KA (2009) Boric acid localization and effects on storage calcium release and the endoplasmic reticulum in prostate cancer cells. Dissertation, University of California Los AngelesGoogle Scholar
- 24.ATCC. https://www.atcc.org. Accessed 22 Jan 2016
- 28.Forbes S, Beare D, Gunasekaran P, Leung K, Bindal N, et al. (2015) COSMIC: exploring the world’s knowledge of somatic mutations in human cancer. Nucl Acids Res 43 (D!): D805-D811.Google Scholar
- 30.Spirin AS (1996) Masked and translatable messenger ribonucleoproteins in higher eukaryotes. In: Hershey SWB, Mathews MB, Sonenberg N (eds) Translational control. Cold Spring Harbor Lab. Press, Cold Spring Harbor, NY, pp. 319–334Google Scholar
- 33.Brush MH, Weiser DC, Shenolikar S (2003) Growth/arrest and DNA damage-inducible protein GADD34 targets protein phosphatase 1α to the endoplasmic reticulum and promote dephosphorylation of the α subunit of eukaryotic translation initiation factor 2. Mol Cell Biol 23:1292–1303CrossRefPubMedPubMedCentralGoogle Scholar
- 34.Hendershot LM (2004) The ER chaperone BiP is the master regulator of ER function. Mount Sinai. J Med 71:289–297Google Scholar
- 38.Conn PM (2011) In: Conn PM (ed) Methods in enzymology. Academic Press, LondonGoogle Scholar
- 41.Ensemble. http://www.ensembl.org/index.html. Accessed 15 Jan 2016
- 58.Belal C, Ameli NJ, El Kommos A, Bezalel S, Al’Khafaji AM, et al. (2012) The homocysteine-inducible endoplasmic reticulum (ER) stress protein Herp counteracts mutant α-synuclein-induced ER stress via the homeostatic regulation of ER-resident calcium release channel proteins. Hum Mol Genet 21:963–977CrossRefPubMedGoogle Scholar
- 66.Trombetta ES (2003) The contribution of N-glycans and their processing in the endoplasmic reticulum to glycoprotein biosynthesis. Glycobiology 13: 77R-91R.Google Scholar
- 68.Gao B, Adhikari R, Howarth M, Nakamura K, Gold MC, et al. (2002) Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone. Immunity:99–109Google Scholar
- 73.Bradke TM, Hall C, Carper SW, Plopper GE (2008) Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability. Cell Adhesion and. Migration 2:153–160Google Scholar
- 82.Yue J, Wei W, Lam CMC, Zhao Y-J, Dong M, et al. (2009) CD38/cADPR/Ca2 pathway promotes cell proliferation and delays nerve growth factor-induced differentiation in PC12 cells*. J Biol Chem 284: 29335–29335.Google Scholar
- 87.O’Neill MA, Warrenfeltz D, Kates K, Pellerin P, Doco T, et al. (1996) Rhamnogalacturonan-II, a pectic polysaccharide in the walls of growing plant cell, forms a dimer that is covalently cross-linked by a borate ester. In vitro conditions for the formation and hydrolysis of the dimer. J Biol Chem 271:22923–22930CrossRefPubMedGoogle Scholar
- 93.WHO (1998) Boron, environmental health criteria 204. International Programme on Chemical Safety. World Health Organization, Geneva, pp 61–65Google Scholar
- 94.Jansen A, Andersen J, Schou JS (1984) Boric acid single dose pharmacokinetics after intravenous administration to man. Arch Toxicol 55:64–67Google Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.